AI Evaluation of Diabetic Retinopathy and Liver Disease in Japan
Author Information
Author(s): Komatsu Koji, Sano Kei, Fukai Kota, Nakagawa Ryo, Nakagawa Takashi, Tatemichi Masayuki, Nakano Tadashi
Primary Institution: Jikei University School of Medicine, Tokyo, Japan
Hypothesis
This study aimed to evaluate fundus photographs using artificial intelligence to explore the relationships between diabetic retinopathy (DR), metabolic dysfunction-associated steatotic liver disease (MASLD), and related factors.
Conclusion
The study demonstrates that MASLD is associated with a reduced risk of diabetic retinopathy, with higher cholinesterase levels providing further protective effects.
Supporting Evidence
- MASLD affects 30% of the general adult population and 60-70% of patients with diabetes and obesity.
- Diabetic retinopathy is a common complication of diabetes and has been linked to liver disease.
- AI software RetCAD achieved a 95.1% area under the ROC curve for detecting diabetic retinopathy.
Takeaway
This study used AI to look at eye pictures from people with diabetes and found that those with liver disease might have a lower chance of eye problems.
Methodology
This cross-sectional study analyzed fundus photographs of 1,736 patients with diabetes using AI software to evaluate diabetic retinopathy and assessed liver disease stages through ultrasound.
Potential Biases
Potential misclassification of diabetic retinopathy due to varying experience levels of ophthalmologists.
Limitations
The study is cross-sectional, making it difficult to establish causality, and it may have omitted peripheral retinal changes due to the use of posterior-pole fundus images.
Participant Demographics
Participants were aged 35-75 years, with a male predominance (77.9%).
Statistical Information
P-Value
0.02
Confidence Interval
0.43–0.95
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website